E Ferrannini Selected Research

iodo- insulin

1/2002

In vivo imaging of insulin receptors by PET: preclinical evaluation of iodine-125 and iodine-124 labelled human insulin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

E Ferrannini Research Topics

Disease

35	Insulin Resistance 01/2020 - 06/2000
34	Type 2 Diabetes Mellitus (MODY) 01/2022 - 08/2000
10	Obesity 08/2015 - 08/2000
9	Weight Loss (Weight Reduction) 01/2022 - 01/2001
9	Glucose Intolerance 04/2010 - 09/2002
7	Body Weight (Weight, Body) 08/2015 - 01/2002
7	Hypothyroidism 07/2005 - 09/2000
6	Atherosclerosis 06/2014 - 08/2006
6	Essential Hypertension 04/2012 - 11/2000
5	Hypertension (High Blood Pressure) 04/2012 - 06/2001
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 08/2000
4	Weight Gain 10/2011 - 11/2007
3	Inflammation (Inflammations) 01/2020 - 08/2006
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2014 - 07/2004
3	Morbid Obesity 09/2011 - 01/2009
3	Myocardial Infarction 08/2011 - 03/2001
3	Thyroid Diseases (Thyroid Disease) 07/2005 - 08/2000
3	Hyperinsulinism (Hyperinsulinemia) 08/2001 - 11/2000
2	Neoplasms (Cancer) 01/2020 - 04/2004
2	Vascular Diseases (Vascular Disease) 06/2014 - 08/2006
2	Urinary Tract Infections (Urinary Tract Infection) 08/2013 - 05/2013
2	Infections 08/2013 - 05/2013
2	Coronary Disease (Coronary Heart Disease) 05/2012 - 03/2006
2	Stroke (Strokes) 08/2011 - 03/2006
2	Non-alcoholic Fatty Liver Disease 04/2009 - 04/2005
2	Overweight 08/2006 - 08/2000
2	Multiple Sclerosis 07/2005 - 04/2004
2	Hyperthyroidism 08/2004 - 04/2004
2	Graves Disease (Basedow Disease) 04/2004 - 12/2001
2	Albuminuria 03/2003 - 06/2001
2	Hyperglycemia 01/2001 - 08/2000
1	Immune System Diseases (Immune Disorders) 01/2020
1	Nasopharyngitis 08/2013
1	Abdominal Obesity 05/2012
1	Isolated Systolic Hypertension 04/2012

Drug/Important Bio-Agent (IBA)

36	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 05/2000
26	Insulin (Novolin)FDA Link 01/2020 - 10/2000
6	LipidsIBA 06/2014 - 10/2001
5	Metformin (Glucophage)FDA LinkGeneric 05/2013 - 03/2006
5	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 04/2012 - 08/2006
4	ChemokinesIBA 01/2014 - 08/2006
4	AutoantibodiesIBA 08/2004 - 12/2001
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 11/2014
3	LigandsIBA 01/2014 - 08/2008
3	Triglycerides (Triacylglycerol)IBA 05/2012 - 12/2007
3	Pioglitazone (Actos)FDA Link 08/2011 - 04/2001
3	CytokinesIBA 11/2008 - 07/2005
3	Atrial Natriuretic Factor (ANF)IBA 03/2003 - 06/2001
2	IncretinsIBA 12/2017 - 12/2006
2	Glucagon (Glukagon)FDA Link 11/2013 - 11/2007
2	Sodium-Glucose Transporter 2 InhibitorsIBA 08/2013 - 05/2013
2	HDL CholesterolIBA 05/2012 - 08/2011
2	CXC ChemokinesIBA 04/2012 - 08/2008
2	Lipoproteins (Lipoprotein)IBA 03/2011 - 05/2004
2	glimepiride (Amarel)FDA LinkGeneric 09/2010 - 02/2009
2	VildagliptinIBA 09/2010 - 02/2009
2	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 09/2009 - 09/2000
2	EnzymesIBA 04/2009 - 12/2001
2	AdiponectinIBA 04/2009 - 09/2006
2	LeptinIBA 01/2009 - 09/2006
2	Acetylcholine (Acetylcholine Chloride)FDA Link 05/2008 - 11/2000
2	Proteins (Proteins, Gene)FDA Link 12/2007 - 02/2005
2	HomocysteineIBA 10/2006 - 08/2006
2	PotassiumIBA 03/2006 - 03/2001
2	InterferonsIBA 07/2005 - 04/2004
2	GlycogenIBA 04/2005 - 01/2001
2	Thyroxine (Levothyroxine)FDA LinkGeneric 05/2004 - 03/2001
2	Adrenergic Agents (Adrenergic Drugs)IBA 01/2001 - 12/2000
1	Dihydrotachysterol (AT 10)IBA 01/2022
1	Mannose (D-Mannose)IBA 01/2020
1	Phenobarbital (Luminal)FDA Link 08/2015
1	Sitagliptin Phosphate (Januvia)FDA Link 11/2014
1	Nonesterified Fatty Acids (NEFA)IBA 11/2014
1	Amino Acids FDA Link 11/2014
1	Fatty Acids (Saturated Fatty Acids)IBA 06/2014
1	Oxidants (Oxidizing Agents)IBA 06/2014
1	Glucagon-Like Peptide 1 (GLP 1)IBA 11/2013
1	GhrelinIBA 11/2013
1	Pancreatic Polypeptide (Pancreatic Polypeptide (PP))IBA 11/2013
1	Islet Amyloid PolypeptideIBA 11/2013
1	empagliflozinIBA 08/2013
1	SymportersIBA 05/2013
1	SodiumIBA 05/2013
1	ipragliflozinIBA 05/2013
1	BradykininIBA 07/2012
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 06/2012
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 10/2011
1	muraglitazarIBA 10/2011
1	5'-palmitoyl cytarabine (PLAC)IBA 10/2011
1	HDL LipoproteinsIBA 08/2011
1	Tissue Inhibitor of MetalloproteinasesIBA 12/2009
1	P-SelectinIBA 12/2009
1	Interleukin-6 (Interleukin 6)IBA 12/2009
1	Matrix Metalloproteinases (MMPs)IBA 12/2009

Therapy/Procedure

11	Therapeutics 05/2013 - 08/2000
5	Glycemic Control 01/2022 - 08/2000
4	Gastric Bypass (Roux-en-Y Gastric Bypass) 01/2022 - 08/2011
4	Bariatric Surgery 01/2022 - 01/2009
2	Biliopancreatic Diversion 01/2009 - 09/2006
1	Gastrectomy 11/2013